Showing 3131-3140 of 6035 results for "".
- Regenxbio Announces License Agreement with Clearside Biomedical for Evaluation of In-Office Delivery Platform for RGX-314https://modernod.com/news/regenxbio-announces-exclusive-worldwide-license-agreement-with-clearside-biomedical-for-evaluation-of-in-office-delivery-platform-for-rgx-314/2476851/Regenxbio and Clearside Biomedical announced an option and license agreement for exclusive worldwide rights to Clearside’s proprietary, in-office SCS Microinjector for the delivery of RGX-314 to the suprachoroidal space to treat wet age-related macular degeneration (AMD), diabetic
- The American Academy of Optometry Foundation Selects the 2019 Bert C. and Lydia M. Corwin Contact Lens Residency Award Recipienthttps://modernod.com/news/the-american-academy-of-optometry-foundation-selects-the-2019-bert-c-and-lydia-m-corwin-contact-lens-residency-award-recipient/2476831/The American Academy of Optometry has named Jocelyn Ou, OD, this year’s recipient of the Bert C. and Lydia M. Corwin Contact Lens Residency award. Dr. Ou is a cornea and contact lens resident at the Ketchum Health University Eye Center in Anaheim, California, and was ch
- RightEye: New Research Demonstrates Reliability of Eye Tracking Data to Identify and Measure Severity of Traumatic Brain Injurieshttps://modernod.com/news/righteye-new-research-demonstrates-reliability-of-eye-tracking-data-to-identify-and-measure-severity-of-traumatic-brain-injuries/2476832/RightEye announced the results of a recent study published in the peer-reviewed journal Concussion that shows how RightEye’s FDA-cleared technology accurately measures deficits in certain eye movements that r
- New World Medical Launches Ahmed ClearPath Glaucoma Drainage Devicehttps://modernod.com/news/new-world-medical-launches-ahmed-clearpath-glaucoma-drainage-device/2476814/New World Medical announced the launch of the Ahmed ClearPath glaucoma drainage device, which is available in two sizes, 350 mm2 and 250 mm.2 A unique feature of the Ahmed ClearPath implant is a flexible plate with a contour that closely conforms to the curvature of the eye
- MIGS Devices Continue to Expand Use of Glaucoma Surgeryhttps://modernod.com/news/migs-devices-continue-to-expand-use-of-glaucoma-surgery/2476811/Minimally invasive glaucoma surgery (MIGS) stents account for nearly half of all glaucoma surgical device revenue in 2019, according to a Market Scope report. Market penetration of these stents over the past 5 years has been impressive, but the voluntary recall of the Alcon CyPass in 2018
- Alcon to Launch Precision1 Daily Disposable Contact Lenseshttps://modernod.com/news/alcon-to-launch-precision1-daily-disposable-contact-lenses/2476810/Alcon announced plans to launch Precision1 daily disposable, silicone hydrogel (SiHy) contact lenses in the United States. Precision1 features Alcon’s proprietary Smartsurface technology—a permanent, micro-thin, high-performance layer of moisture at the lens surface that helps support a stable te
- AcuFocus Completes Study Enrollment for U.S. IDE Clinical Trial of IC-8 Lenshttps://modernod.com/news/acufocus-completes-study-enrollment-for-u-s-ide-clinical-trial-of-ic-8-lens/2476806/AcuFocus announced that it has completed enrollment in its pivotal US investigational device exemption (IDE) study of the company’s IC-8 small aperture IOL. FDA granted approval of the company’s IDE on November 21, 2018, and the Investigational Review Board approved the study just 5
- Study: Yellow Lens Glasses Don’t Improve Drivers’ Night Visionhttps://modernod.com/news/study-yellow-lens-glasses-dont-improve-drivers-night-vision/2476789/Touted to improve nighttime eyesight, yellow lens glasses don’t help drivers see better and may, in fact, worsen vision, a new study suggests, Reuters Health reported. Researchers found that yellow-lens wearing volunteers ope
- Clearside Biomedical Announces Multiple Presentations Delivered at the ASRS Annual Meetinghttps://modernod.com/news/clearside-biomedical-announces-multiple-presentations-delivered-at-the-asrs-annual-meeting/2479557/Clearside Biomedical announced that multiple oral presentations were delivered on Clearside’s pipeline and proprietary SCS Microinjector targeting the suprachoroidal space (SCS) at the American Society of Retinal Specialists (ASRS) Annual Meeting. “Clearside had a widespread presence at t
- EssilorLuxottica, Maker of Ray-Ban Sunglasses, Agrees to Buy GrandVision in $8 Billion Dealhttps://modernod.com/news/ray-ban-maker-agrees-to-buy-grandvision-for-8-billion/2479558/A blockbuster deal in the eyecare retail space was announced on Wednesday as EssilorLuxottica, the maker of Ray-Ban sunglasses, agreed to buy Dutch retailer GrandVision NV in multi-billion dollar deal. Paris-based EssilorLuxottica agreed to buy control (77%) of European rival GrandVision f